• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Silence Therapeutics Plc - American Depository Share (NQ:SLN)

13.88 +0.30 (+2.25%)
Streaming Delayed Price Updated: 2:09 PM EDT, Aug 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Silence Therapeutics Plc - American Depository Share

< Previous 1 2 3 4 5 6 Next >
News headline image
Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering
August 11, 2026
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics’ Divesiran Hits Phase II Goal, Sets Up Phase III PV Trial ↗
August 11, 2026
Silence Therapeutics (NASDAQ:SLN) reported top-line results from its Phase II SANRECO trial of divesiran in patients with phlebotomy-dependent polycythemia vera, or PV, with the study meeting its... 
Via MarketBeat
News headline image
Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
August 10, 2026
From Silence Therapeutics plc
Via Business Wire
There are notable gap-ups and gap-downs in today's session. ↗
August 10, 2026
Via Chartmill
Wondering what's happening in today's pre-market session? ↗
August 10, 2026
Via Chartmill
News headline image
Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile
August 10, 2026
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics Reports Second Quarter 2026 Financial and Business Results
August 10, 2026
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera
August 09, 2026
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera
June 11, 2026
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics to Participate in Jefferies Global Healthcare Conference
May 27, 2026
From Silence Therapeutics plc
Via Business Wire
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
May 12, 2026
Via Chartmill
News headline image
Silence Therapeutics to Participate in H.C. Wainwright BioConnect Investor Conference
May 12, 2026
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics Highlights Recent Business Achievements and Reports First Quarter 2026 Financial Results
May 07, 2026
From Silence Therapeutics plc
Via Business Wire
Keep an eye on the top gainers and losers in Wednesday's session. ↗
May 06, 2026
Via Chartmill
Traders are paying attention to the gapping stocks in Wednesday's session. ↗
April 29, 2026
Via Chartmill
Top movers in Thursday's session ↗
April 23, 2026
Via Chartmill
Monday's session: gap up and gap down stocks ↗
April 06, 2026
Via Chartmill
Here are the top movers in Monday's session. ↗
March 30, 2026
Via Chartmill
Top stock movements in today's session. ↗
March 27, 2026
Via Chartmill
Keep an eye on the top gainers and losers in Friday's session. ↗
March 27, 2026
Via Chartmill
Which stocks are gapping on Friday? ↗
March 27, 2026
Via Chartmill
Top movers analysis one hour before the close of the markets on 2026-03-26: top gainers and losers in today's session. ↗
March 26, 2026
Via Chartmill
Here are the top movers in Thursday's session. ↗
March 26, 2026
Via Chartmill
These stocks that are showing activity before the opening bell on Thursday. ↗
March 26, 2026
Via Chartmill
Top movers in Friday's session ↗
March 20, 2026
Via Chartmill
Which stocks are moving on Thursday? ↗
March 12, 2026
Via Chartmill
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
March 05, 2026
Via Chartmill
News headline image
Silence Therapeutics Highlights Recent Business Achievements and Reports Fourth Quarter and Full Year 2025 Financial Results
March 05, 2026
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics Announces Leadership Changes
December 15, 2025
From Silence Therapeutics plc
Via Business Wire
News headline image
Bausch Health’s Slow Rebuild Faces New Scrutiny After Lombard Odier Cuts Its Stake ↗
December 10, 2025
Bausch Health’s valuation suggests potential, but the stake cut shows how far the company still has to go to earn back full investor confidence. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap